Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute

罗斯威尔帕克癌症研究所网络领导学术参与站点资助

• 批准号: 10590763
• 负责人: SHASHIKANT LELE
• 金额: $ 39.9万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-03-06 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10590763
• 关键词: Benign; Biological; Biometry; Cancer Biology; Cancer Patient; Clinical Data; Clinical Protocols; Clinical Research; Clinical Treatment; Clinical Trials; Data; Enrollment; Grant; Imaging Techniques; Institution; Knowledge; Lead; Malignant - descriptor; Manuscripts; Molecular; Operative Surgical Procedures; Patient advocacy; Patients; Phase; Populations at Risk; Preparation; Process; Productivity; Protocols documentation; Quality of life; Radiation; Radiology Specialty; Research; Research Personnel; Resources; Roswell Park Cancer Institute; Site; Specimen; Techniques; Therapeutic; cancer prevention; cancer therapy; data submission; experience; improved; inter-institutional; member; novel therapeutics; premalignant; prognostic; rare cancer; response; therapy resistant; timeline; treatment trial

PROJECT SUMMARY The Roswell Park Cancer Institute has had a long tradition of contributing to the national cooperative groups over many decades. Those contributions have been scientific, administrative, and participatory (enrollment on clinical trials). Contributions have been consistent and numerous over the years. This application summarizes the intent of its 4 Co-PIs (Levine/Ernstoff/Lele/Singh) and the membership of RPCI to sustain its commitment to the many strengths inherent to cooperative group research: therapeutic advances; a better understanding of the biology of cancer; cancer prevention; means to improve the quality of life of cancer patients; piloting of new drugs and radiologic and radiation and surgical techniques; establishing the relevance of new cellular and molecular advances to the predictive, prognostic, and therapeutic approaches to patients; and the advancement of patient advocacy. Investigators at RPCI and its supporting staff fully recognize the essential importance of the timely and accurate submission of data and specimens to achieve these aims.

项目总结